WASHINGTON – The Biotechnology Innovation Organization (BIO) today announced that industry veteran Jim Greenwood will step down as President and CEO of the world’s largest biotechnology organization after the 2020 election and help transition a new leader to represent the industry globally and to defend innovation from domestic political attacks.Continue reading→

Oncology Pharma is pleased to announce that Kalos Therapeutics’ lead compound, KTH-222, can produce a reduction in the attachment of newly seeded cells to a solid-phase by an average of 39%. These non-clinical results suggest that KTH-222 disrupt tubulin formation and attachment to the solid-phase in a similar way to most of the commonly used tubulin disrupting chemotherapeutic drugs. However, the mechanism of action by KTH-222 may be different than the most commonly used tubulin-disrupting therapies and needs further investigation. Continue reading→

The $120 million Biodesign Institute C research building at Arizona State University (ASU), which was constructed by McCarthy Building Companies and completed in June 2018, recently received LEED Platinum certification from the U.S. Green Building Council.Continue reading→

For more than a decade, scientist Stephen Albert Johnston and his team at Arizona State University’s Biodesign Institute have pooled their energies into an often scoffed-at, high-risk, high-reward goal in medicine: to develop a universal vaccine to prevent cancer.Continue reading→

Results to date demonstrate that Cereset’s technology may help U.S. military personnel suffering from concussionContinue reading→

New Campaign Brings Awareness About the Importance of Flu Vaccination to AZ StudentsContinue reading→

DNA-based pathogen testing company completes funding round led by Cresco Capital Partners in just three monthsContinue reading→

Continue reading→